F
ForagR Medicines utilizes an RNA-centric, in-cell framework that employs chemical genomics to address disease origins. Their platform is designed to overcome common hurdles in small-molecule RNA-targeted medicines, specifically selectivity, progressability, and function. The company performs screening, hit-to-lead, and lead optimization directly within cells to efficiently derisk targets and achieve functional modulation.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ForagR Medicines utilizes an RNA-centric, in-cell framework that employs chemical genomics to address disease origins. Their platform is designed to overcome common hurdles in small-molecule RNA-targeted medicines, specifically selectivity, progressability, and function. The company performs screening, hit-to-lead, and lead optimization directly within cells to efficiently derisk targets and achieve functional modulation.